Sol-Gel Technologies Ltd. (SLGL)
NASDAQ: SLGL · Real-Time Price · USD
0.534
+0.050 (10.33%)
Nov 22, 2024, 4:00 PM EST - Market closed
Sol-Gel Technologies Employees
Sol-Gel Technologies had 36 employees as of December 31, 2023. The number of employees decreased by 19 or -34.55% compared to the previous year.
Employees
36
Change (1Y)
-19
Growth (1Y)
-34.55%
Revenue / Employee
$325,194
Profits / Employee
-$265,833
Market Cap
14.88M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Trinity Biotech | 380 |
Cosmos Health | 123 |
Lyra Therapeutics | 88 |
Aspira Women's Health | 64 |
AIM ImmunoTech | 28 |
Sensei Biotherapeutics | 28 |
Talphera | 15 |
QT Imaging Holdings | 14 |
SLGL News
- 8 days ago - Sol-Gel Reports Third Quarter 2024 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 3 months ago - UPDATE: Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 3 months ago - Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 4 months ago - Sol-Gel Technologies Announces Management Realignment - GlobeNewsWire
- 6 months ago - Sol-Gel Reports First Quarter 2024 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 6 months ago - Sol-Gel and Beimei Pharma Announce an Asset Purchase Agreement to Commercialize TWYNEO® in the Mainland of China, Hong Kong, Macau, Taiwan and Israel - GlobeNewsWire
- 8 months ago - Sol-Gel's Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream - GlobeNewsWire
- 9 months ago - Sol-Gel Reports Full-Year 2023 Financial Results and Corporate Developments - GlobeNewsWire